Direct clinical and welfare costs of osteoporotic fractures in elderly men and women

Osteoporosis is an increasing health care problem in all aging populations, but overall direct costs associated with the total fracture burden of osteoporosis remain uncertain. We have examined direct costs associated with 151 osteoporotic fractures occurring between 1989 and 1992 in a large cohort of elderly men and women followed prospectively as part of the Dubbo Osteoporosis Epidemiology Study. The median cost of hospital treated fractures was $A10 511 per fracture and for fractures treated on an outpatient basis $A455 in 1992 Australian dollars. Femoral neck fractures were the most expensive fractures ($15984 median cost). There was no significant difference in costs between men and women for either hospital- or outpatient-treated fractures. Rehabilitation hospital costs comprised the largest proportion of costs (49%) for hospital-treated fractures. Community services comprised the major cost (40%) of outpatient-treated fractures. Univariate predictors of costs were quadriceps strength and bone density, although multivariate analysis showed quadriceps strength to be the best overall predictor of costs. The predicted annual treatment costs in Australia for atraumatic fractures occurring in subjects ⩾60 years was $A779 million or approximately $A44 million per million of population per annum. Estimated total osteoporotic fracture-related costs for the Australian population were much higher than previously reported. The majority of direct costs (95%) were incurred by hospitalized patients and related to hospital and rehabilitation costs. Extrapolation of these data suggests that the direct costs for hip fracture alone will increase approximately twofold in most Western countries by 2025. Improving the cost-effectiveness of treating osteoporotic fractures should involve reduced hospitalization and/or greater efficiency in community rehabilitation services. The costs of various approaches to osteoporosis prevention must be placed into the context of these direct costs and prevention should target men as well as women.

[1]  J L Kelsey,et al.  Epidemiology of osteoporosis and osteoporotic fractures. , 1985, Epidemiologic reviews.

[2]  S. Cummings,et al.  The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. , 1990, Clinical orthopaedics and related research.

[3]  S. Lord,et al.  Prediction of osteoporotic fractures by postural instability and bone density. , 1993, BMJ.

[4]  J. Kanis The incidence of hip fracture in Europe , 2005, Osteoporosis International.

[5]  J. Eisman,et al.  Mechanisms of rapid bone loss following cardiac transplantation , 1994, Osteoporosis International.

[6]  S. Lord,et al.  Postural stability, falls and fractures in the elderly: results from the Dubbo Osteoporosis Epidemiology Study , 1994 .

[7]  O. Johnell,et al.  Consequences of a hip fracture: A prospective study over 1 year , 1993, Osteoporosis International.

[8]  J. Kanis,et al.  Epidemiology of osteoporosis. , 1992, Bone.

[9]  E. Lévy Cost analysis of osteoporosis related to untreated menopause , 1989, Clinical Rheumatology.

[10]  J. Eisman,et al.  Symptomatic fracture incidence in elderly men and women: The Dubbo osteoporosis epidemiology study (DOES) , 1994, Osteoporosis International.

[11]  A P Cheung,et al.  A cost‐effectiveness analysis of hormone replacement therapy in the menopause∗ , 1992, The Medical journal of Australia.

[12]  S Phillips,et al.  The direct medical costs of osteoporosis for American women aged 45 and older, 1986. , 1988, Bone.

[13]  M. Weinstein,et al.  Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. , 1990, Annals of internal medicine.

[14]  R. Norris Medical costs of osteoporosis. , 1992, Bone.

[15]  J. Schuttinga,et al.  Targeted estrogen/progestogen replacement therapy for osteoporosis: calculation of health care cost savings , 1992, Osteoporosis International.

[16]  C. Cooper,et al.  Hip fractures in the elderly: A world-wide projection , 1992, Osteoporosis International.

[17]  M. Weinstein,et al.  Cost-effectiveness of hormone replacement therapy in the menopause. , 1983, Obstetrical & gynecological survey.

[18]  J. Simons,et al.  The Dubbo study: an Australian prospective community study of the health of elderly. , 1990, Australian and New Zealand journal of medicine.